-PTI New Delhi: The drug price regulator has sought details of patented medicines as part of a drive to fix their rates. The National Pharmaceutical Pricing Authority (NPPA) is also fixing the price ceiling for 102 drugs on the National List of essential medicines (NLEM) and has asked for financial data, like retail rates and the firms' turnover. On patented drugs imported or manufactured for sale in India, the NPPA has called for...

-The Times of India The union health ministry's target of distributing 50 drugs free under the free essential drug scheme is so much lower than the hundreds of drugs being provided by states with a functioning free drugs scheme that it has left health officials in these states puzzled. After starting off by talking of distributing 348 drugs in the National List of essential medicines (NLEM) during the tenure of Dr Harsh...

-The Telegraph New Delhi: International health activists have joined their Indian counterparts in decrying what they say are Barack Obama's dual policy on big drug companies, pledging to break their stranglehold in the US but promoting their interests in India. The activists claimed yesterday that the India-US joint statement, issued during Obama's visit to India, contains signals that the Indian government could be preparing to weaken its intellectual property regulations on medicines,...

-The Times of India NEW DELHI: Leading US health groups including AVAC, Oxfam America, amfAR, Health Global Access Project (GAP), TAG (Treatment Action Group)and others have written to Barack Obama urging him to support India in providing "high-quality, low-cost generic medicines essential for health care around the world". This comes in the wake of the two nations agreeing to enhance engagement on IPR at the latest bilateral talks. Sunday's joint statement after...

-The Times of India NEW DELHI: The government may negotiate prices of patented medicines with their manufacturers before allowing pharmaceutical companies to launch them in India. The move, a first of its kind, is also likely to be applied on patented drugs that are already being sold in the country, an official source said. An inter-ministerial committee, evaluating the mechanism to negotiate prices of patented medicines, has recently sought detailed information about...